Concepedia

Georg Neckermann

GN

Statistics

Publications

16

Citations

584

H-Index

14

Active since

1993

Affiliations

Novartis (United States)(Current)

Novartis (Switzerland)

AstraZeneca (United States)

Program for Appropriate Technology in Health

Novartis Institutes for BioMedical Research

Georg Neckermann is an author at Novartis (United States) specializing in pharmacology, pharmacy, and medicinal chemistry.

Publications per year

1993–2016

16

Publications

16

Intestinal absorption of peptides by coupling to bile acids.

Werner Kramer, Günther Wess, Georg Neckermann et al. · Journal of Biological Chemistry · 1994 · 80 citations · Full text

, , +17

Bile acid derived HMG-CoA reductase inhibitors

Werner Kramer, Günther Wess, Alfons Enhsen et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 1994 · 53 citations

, , +10

Immunization with recombinant woodchuck hepatitis virus nucleocapsid antigen or hepatitis B virus nucleocapsid antigen protects woodchucks from woodchuck hepatitis virus infection

F. Schödel, Georg Neckermann, Darrell L. Peterson et al. · Vaccine · 1993 · 48 citations

, , +14

Atopic dermatitis-like symptoms in hypomagnesaemic hairless rats are prevented and inhibited by systemic or topical SDZ ASM 981

Georg Neckermann, A. Bavandi, Josef G. Meingassner · British Journal of Dermatology · 2000 · 47 citations

, , +16

Discovery of Inhibitors of 4′-Phosphopantetheine Adenylyltransferase (PPAT) To Validate PPAT as a Target for Antibacterial Therapy

Boudewijn L. M. de Jonge, Grant K. Walkup, Sushmita D. Lahiri et al. · Antimicrobial Agents and Chemotherapy · 2013 · 44 citations · Full text

, , +17

1–5 of 16